First-line therapy for metastatic colorectal cancer: Current perspectives and future directions-Reference-Cited by-同舟云学术

First-line therapy for metastatic colorectal cancer: Current perspectives and future directions

Published:2019-02 Issue: Volume:15 Page:3-14
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clin Oncol

Author:

Burge Matthew¹,Price Timothy¹,Karapetis Christos S.¹

Affiliation:

1. Department of Cancer Care Services; Royal Brisbane Hospital; University Of Queensland; Herston Queensland

Publisher

Wiley

Subject

Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.13119/fullpdf

Reference93 articles.

1. AIHW Cancer compendium: information and trends by cancer type https://www.aihw.gov.au/reports/cancer/cancer-compendium-information-and-trends-by-cancer-type/report-contents/colorectal-cancer-in-australia

2. Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer: a randomized clinical trial;Venook;JAMA,2017

3. Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomised trials;Arnold;Ann Oncol,2017

4. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location;Bufill;Ann Intern Med,1990

5. Are there two sides to colorectal cancer?;Iacopetta;Int J Cancer,2002

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estrogen treatment in combination with pyruvate kinase M2 inhibition precipitate significant cumulative antitumor effects in colorectal cancer;Journal of Biochemical and Molecular Toxicology;2024-08

2. Exploring the Relationship Between KRAS, NRAS, and BRAF Mutations and Clinical Characteristics in Iranian Colorectal Cancer Patients;Journal of Gastrointestinal Cancer;2024-05-06

3. IL-6, TNF-α and IL-12p70 levels in patients with colorectal cancer and their predictive value in anti-vascular therapy;Frontiers in Oncology;2022-09-26

4. Mutational landscape of circulating tumor DNA identifies distinct molecular features associated with therapeutic response in patients with metastatic colorectal cancer;Therapeutic Advances in Medical Oncology;2022-01

5. Imaging predictors of BRAF mutation in colorectal cancer;Abdominal Radiology;2020-03-19